問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK-2870-036
NCT Number(ClinicalTrials.gov Identfier)-
Active

2025-10-01 - 2034-05-31

Phase III

Recruiting5

ICD-10C53.9

Malignant neoplasm of cervix uteri, unspecified

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9180.9

Malignant neoplasm of cervix uteri, unspecified

-

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/13

Investigators and Locations

Principal Investigator Yu-Fang Huang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yun-Hsin Tang Division of Obstetrics & Gynecology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 張志隆 Division of Obstetrics & Gynecology

Co-Principal Investigator

  • 王功亮 Division of Obstetrics & Gynecology
  • 陳楨瑞 Division of Obstetrics & Gynecology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chien-Hsing Lu Division of Obstetrics & Gynecology

Co-Principal Investigator

  • 石宇翔 Division of Obstetrics & Gynecology
  • 孫珞 Division of Obstetrics & Gynecology
  • 劉芝谷 Division of Obstetrics & Gynecology
  • 王韶靖 Division of Obstetrics & Gynecology
  • 范鈞婷 Division of Obstetrics & Gynecology
  • 黃曉峰 Division of Obstetrics & Gynecology
  • 吳振豪 Division of Radiology
  • 許世典 Division of Obstetrics & Gynecology
  • 呂亭芳 Division of Obstetrics & Gynecology
  • 陳彥甫 Division of Obstetrics & Gynecology

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator CHI-HAU CHEN CHI-HAU CHEN

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    20 participants

  • Global

    1023 participants